The side effects of Febuxostat/Febuxostat
Febuxostat (Febuxostat), as an effective urate-lowering drug, is widely used to treat patients with hyperuricemia and gout. Although the drug has shown clinically significant efficacy in helping to control high uric acid levels and reduce gout attacks, it can also cause some side effects that may vary in severity among different patient groups.
The most common side effect of febuxostat is abnormal liver function. Especially under long-term use, patients may experience an increase in liver function indicators (such asincreased ALT and AST). Most of these liver function abnormalities are mild, but in patients with existing liver problems, or in people with poor liver function, long-term use of febuxostat may cause more serious liver damage. Severe liver damage may lead to liver failure and even be life-threatening, so liver function needs to be monitored regularly and treatment plans adjusted in a timely manner.
Another potential side effect is an increased risk of cardiovascular events. Although febuxostat is very effective in controlling gout and hyperuricemia, some studies have found that the drug may be associated with the occurrence of cardiovascular events. For example, febuxostat may increase the risk of cardiovascular problems such as heart disease and stroke in some high-risk groups. Therefore, patients with a history of cardiovascular disease or higher cardiovascular risks need to be particularly cautious when using febuxostat, conduct regular cardiovascular health assessments, and use it under the guidance of a doctor.
In addition, febuxostat may cause allergic reactions, although this is rare. Signs of an allergic reaction may include rash, hives, shortness of breath, etc. If patients develop these symptoms while taking febuxostat, they should stop taking the drug immediately and seek medical advice. Therefore, these patients need to undergo regular renal function testing when using febuxostat and promptly adjust the treatment plan when changes in renal function are found.
Reference materials:https://www.drugs.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)